If you need more lookups,
subscriptions start at $34 USD/month.
Wil Hollander Location
's-Hertogenbosch, NB, NL
Wil Hollander Work
Director Clinical Development @ (January 2022 - Present)
Senior Consultant Clinical Development @ (September 2021 - December 2021)
Senior Director Clinical Science @ (January 2019 - July 2021)
Director Clinical Research @ (March 2015 - December 2018)
Program Manager Migraine @ (August 2012 - October 2014)
Global Trial Manager Neuroscience @ (January 2009 - August 2012)
Clinical Research Scientist Neuroscience @ (January 2007 - January 2009)
Clinical Research Scientist Hormone Replacement Therapy @ (October 2000 - January 2007)
Scientific Editor Regulatory Affairs- Chemical Pharmaceutical and Biotechnological Section @ (January 1998 - September 2000)
Scientific Editor Regulatory Affairs Medical Biological Section @ (April 1996 - December 1997)
Scientist Preclinical Pharmacology (Immunology, Chronic Inflammation) @ Yamanouchi Europe BV, Leiderdorp, The Netherlands (September 1992 - March 1996)
Wil Hollander Education
Leiden University
Master's Degree (Bio-Pharmaceutical Sciences)
1987-1992
Wil Hollander Skills
Clinical Development
Clinical Study Design
Clinical Trials
Protocol
Clinical Pharmacology
European Union
Drug Development
CRO
Pharmacology
Clinical Research
Regulatory Affairs
Immunology
Pharmaceutical Industry
FDA
Biopharmaceuticals
Project Management
GCP
Neuroscience
CTMS
Microsoft Excel
Research
Wil Hollander Summary
Wil Hollander, based in 's-Hertogenbosch, NB, NL, is currently a Director Clinical Development at 3D-PharmXchange. Wil Hollander brings experience from previous roles at 3D-PharmXchange, ProQR Therapeutics, ProQR Therapeutics NV and Merck. Wil Hollander holds a 1987 - 1992 Master's Degree in Bio-Pharmaceutical Sciences @ Leiden University. With a robust skill set that includes Clinical Development, Clinical Study Design, Clinical Trials, Protocol, Clinical Pharmacology and more. Wil Hollander has 1 emails on RocketReach.
Looking for a different Wil Hollander?
Find contact details for 700 million professionals.